These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15464740)
1. Effects of repeated injections of the neurotensin analog NT69L on dopamine release and uptake in rat striatum in vitro. Wang R; Boules M; Tiner W; Richelson E Brain Res; 2004 Oct; 1025(1-2):21-8. PubMed ID: 15464740 [TBL] [Abstract][Full Text] [Related]
2. Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain. Wang R; Boules M; Gollatz E; Williams K; Tiner W; Richelson E Brain Res Mol Brain Res; 2005 Jul; 138(1):24-34. PubMed ID: 15878217 [TBL] [Abstract][Full Text] [Related]
3. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux. Prus AJ; Huang M; Li Z; Dai J; Meltzer HY Brain Res; 2007 Dec; 1184():354-64. PubMed ID: 17988654 [TBL] [Abstract][Full Text] [Related]
4. Rapid desensitization of dopamine release induced by neurotensin and neurotensin fragments. Faggin BM; Cubeddu LX J Pharmacol Exp Ther; 1990 May; 253(2):812-8. PubMed ID: 2338657 [TBL] [Abstract][Full Text] [Related]
5. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate. Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224 [TBL] [Abstract][Full Text] [Related]
6. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain. Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313 [TBL] [Abstract][Full Text] [Related]
7. The neurotensin agonist NT69L improves sensorimotor gating deficits in rats induced by a glutamatergic antagonist, but not by dopaminergic agonists. Secchi RL; Sung E; Hedley LR; Button D; Schreiber R Behav Brain Res; 2009 Sep; 202(2):192-7. PubMed ID: 19463701 [TBL] [Abstract][Full Text] [Related]
8. [Regulation of (-)-sulpiride-induced increase in evoked dopamine release from striatal slices in rat]. Yamada S; Yokoo H; Nishi S Yakubutsu Seishin Kodo; 1992 Aug; 12(4):193-7. PubMed ID: 1414037 [TBL] [Abstract][Full Text] [Related]
9. A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats. Boules M; Oliveros A; Liang Y; Williams K; Shaw A; Robinson J; Fredrickson P; Richelson E Neuropeptides; 2011 Feb; 45(1):9-16. PubMed ID: 21047685 [TBL] [Abstract][Full Text] [Related]
10. NT69L, a novel analgesic, shows synergy with morphine. Boules M; Shaw A; Liang Y; Barbut D; Richelson E Brain Res; 2009 Oct; 1294():22-8. PubMed ID: 19651107 [TBL] [Abstract][Full Text] [Related]
11. Fluoro-gold and pentamidine inhibit the in vitro and in vivo release of dopamine in the striatum of rat. Bowyer JF; Gough B; Broening HW; Newport GD; Schmued L J Pharmacol Exp Ther; 1993 Aug; 266(2):1066-74. PubMed ID: 8355181 [TBL] [Abstract][Full Text] [Related]
12. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat. Boules M; Iversen I; Oliveros A; Shaw A; Williams K; Robinson J; Fredrickson P; Richelson E Brain Res; 2007 Jan; 1127(1):90-8. PubMed ID: 17113052 [TBL] [Abstract][Full Text] [Related]
13. NT69L blocks ethanol-induced increase of dopamine and glutamate levels in striatum of mouse. Li Z; Boules M; Richelson E Neurosci Lett; 2011 Jan; 487(3):322-4. PubMed ID: 20974215 [TBL] [Abstract][Full Text] [Related]
14. Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys. Fantegrossi WE; Ko MC; Woods JH; Richelson E Pharmacol Biochem Behav; 2005 Feb; 80(2):341-9. PubMed ID: 15680187 [TBL] [Abstract][Full Text] [Related]
15. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. Fredrickson P; Boules M; Yerbury S; Richelson E Eur J Pharmacol; 2003 Jan; 458(1-2):111-8. PubMed ID: 12498914 [TBL] [Abstract][Full Text] [Related]
16. Involvement of potentially distinct neurotensin receptors in neurotensin-induced stimulation of striatal [3H]dopamine release evoked by KCl versus electrical depolarization. Heaulme M; Leyris R; Le Fur G; Soubrie P Neuropharmacology; 1997 Oct; 36(10):1447-54. PubMed ID: 9423933 [TBL] [Abstract][Full Text] [Related]
17. Prenatal cocaine exposure decreases nigrostriatal dopamine release in vitro: effects of age and sex. Glatt SJ; Trksak GH; Cohen OS; Simeone BP; Jackson D Synapse; 2004 Aug; 53(2):74-89. PubMed ID: 15170820 [TBL] [Abstract][Full Text] [Related]
18. Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment. Milusheva E; Baranyi M; Kittel A; Sperlágh B; Vizi ES Free Radic Biol Med; 2005 Jul; 39(1):133-42. PubMed ID: 15925285 [TBL] [Abstract][Full Text] [Related]
19. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice. Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157 [TBL] [Abstract][Full Text] [Related]
20. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol. Cusack B; Boules M; Tyler BM; Fauq A; McCormick DJ; Richelson E Brain Res; 2000 Feb; 856(1-2):48-54. PubMed ID: 10677610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]